{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:15:57Z","timestamp":1786122957508,"version":"build-2736575974"},"reference-count":34,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli Lilly"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ferrer"},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Hypertension is a highly common cardiovascular risk factor, and a large proportion of patients with coronary heart disease (CHD) have uncontrolled hypertension. We report on the distribution and determinants of hypertension awareness, treatment, and control in CHD hypertensive patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The EUROASPIRE V survey included 8261 CHD patients from 27 countries. Awareness was defined as patients reporting being told by a health professional to have raised blood pressure (BP), being aware of their BP target and latest measurement. Patients using antihypertensive medication to lower BP were considered treated. Controlled hypertension was defined as BP &amp;lt;140\/90\u2005mmHg (&amp;lt;140\/85\u2005mmHg in patients with diabetes). Factors associated with hypertension awareness, treatment, and control were identified with logistic regression. A total of 6496 EUROASPIRE V patients were considered hypertensive, from which 60.4% were aware, 91.7% were on treatment, and 46.8% were controlled. Number of antihypertensive drugs and adherence were independently associated with awareness (odds ratio 1.23, 95% confidence interval 1.16\u20131.31, and 2.18, 1.74\u20132.74, respectively) and control (1.11, 1.05\u20131.17 and 1.93, 1.57\u20132.37, respectively). Secondary (1.32, 1.03\u20131.68) and tertiary (1.70, 1.32\u20132.17) education and undertaking lifestyle changes (1.60, 1.37\u20131.87) were associated with awareness. Controlled patients were more often aware (1.43, 1.23\u20131.65) and had a healthier risk factor profile (body mass index &amp;gt;25\u2005kg\/m2 0.73, 0.61\u20130.87, diabetes 0.67, 0.59\u20130.76, LDL \u22651.8\u2005mmol\/L 0.75, 0.65\u20130.86) than uncontrolled patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hypertension control remains poor in hypertensive CHD patients, despite high treatment and reasonable awareness levels. Communication with CHD hypertensive patients, especially those from vulnerable groups, needs to improve to facilitate change of health behaviours.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwag377","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:16:53Z","timestamp":1785237413000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypertension awareness, treatment, and control in coronary heart disease patients: results of the EUROASPIRE V survey conducted in 27 countries"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0338-4292","authenticated-orcid":false,"given":"Anna","family":"Marz\u00e0 Florensa","sequence":"first","affiliation":[{"name":"Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University , Heidelberglaan 100, Utrecht 3584 CX ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Jankowski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Geriatric Cardiology, Centre of Postgraduate Medical Education , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9951-5164","authenticated-orcid":false,"given":"Ilonca","family":"Vaartjes","sequence":"additional","affiliation":[{"name":"Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University , Heidelberglaan 100, Utrecht 3584 CX ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-9889","authenticated-orcid":false,"given":"Kerstin","family":"Klipstein-Grobusch","sequence":"additional","affiliation":[{"name":"Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University , Heidelberglaan 100, Utrecht 3584 CX ,","place":["The Netherlands"]},{"name":"Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-1623","authenticated-orcid":false,"given":"Guy","family":"De Backer","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Ghent University , Ghent ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk de","family":"Bacquer","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Ghent University , Ghent ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Kotseva","sequence":"additional","affiliation":[{"name":"National Institute for Prevention and Cardiovascular Health, National University of Galway , Galway ,","place":["Ireland"]},{"name":"Imperial College Healthcare NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[{"name":"National Institute for Prevention and Cardiovascular Health, National University of Galway , Galway ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-3821","authenticated-orcid":false,"given":"Renata","family":"Cifkova","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital , Prague 140 59 ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Letho","sequence":"additional","affiliation":[{"name":"Oulu University Hospital and Lapland Central Hospital , Oulu ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2982-6108","authenticated-orcid":false,"given":"Erkin","family":"Mirrakhimov","sequence":"additional","affiliation":[{"name":"Kyrgyz State Medical Academy , Bishkek ,","place":["Kyrgyzstan"]},{"name":"Seoul University , Seoul ,","place":["South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick E","family":"Grobbee","sequence":"additional","affiliation":[{"name":"Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University , Heidelberglaan 100, Utrecht 3584 CX ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2026080708561535700_zwag377-B1","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/HJH.0000000000002130","article-title":"Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry","volume":"37","author":"C\u00edfkov\u00e1","year":"2019","journal-title":"J Hypertens"},{"key":"2026080708561535700_zwag377-B2","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080708561535700_zwag377-B3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"2026080708561535700_zwag377-B4","first-page":"13","article-title":"Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA project","volume":"13","author":"Antikainen","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026080708561535700_zwag377-B5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/08037050500239962","article-title":"Determinants of poor hypertension management in patients with ischaemic heart disease","volume":"14","author":"Jankowski","year":"2005","journal-title":"Blood Press"},{"key":"2026080708561535700_zwag377-B6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080708561535700_zwag377-B7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ypmed.2010.09.015","article-title":"Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey","volume":"51","author":"Reiner","year":"2010","journal-title":"Prev Med (Baltim)"},{"key":"2026080708561535700_zwag377-B8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12939-016-0478-6","article-title":"Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries","volume":"15","author":"Palafox","year":"2016","journal-title":"Int J Equity Health"},{"key":"2026080708561535700_zwag377-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0084238","article-title":"Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies","volume":"9","author":"Khatib","year":"2014","journal-title":"PLoS One"},{"key":"2026080708561535700_zwag377-B10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gheart.2015.11.003","article-title":"Time trends in lifestyle, risk factor control, and use of evidence-based medications in patients with coronary heart disease in Europe: results from 3 EUROASPIRE surveys, 1999\u20132013","volume":"12","author":"Kotseva","year":"2017","journal-title":"Glob Heart"},{"key":"2026080708561535700_zwag377-B11","author":"The World Bank"},{"key":"2026080708561535700_zwag377-B12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/2047487315601078","article-title":"Educational level and risk profile and risk control in patients with coronary heart disease","volume":"23","author":"Bruthans","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2026080708561535700_zwag377-B13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2026080708561535700_zwag377-B14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2019.09.015","article-title":"Chronic medication intake in patients with stable coronary heart disease across Europe: evidence from the daily clinical practice. Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry","volume":"300","author":"De Smedt","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026080708561535700_zwag377-B15","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080708561535700_zwag377-B16","author":"R Studio Team"},{"key":"2026080708561535700_zwag377-B17","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026080708561535700_zwag377-B18","doi-asserted-by":"crossref","first-page":"e001461","DOI":"10.1136\/openhrt-2020-001461","article-title":"Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK","volume":"8","author":"Tapela","year":"2021","journal-title":"Open Heart"},{"key":"2026080708561535700_zwag377-B19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ije\/dyt215","article-title":"Hypertension among older adults in low and middle-income countries: prevalence, awareness and control","volume":"43","author":"Lloyd-Sherlock","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2026080708561535700_zwag377-B20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejcnurse.2004.05.002","article-title":"Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease","volume":"3","author":"Alm-Roijer","year":"2004","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2026080708561535700_zwag377-B21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1510\/icvts.2005.120956","article-title":"Risk factor awareness and secondary prevention of coronary artery disease: are we doing enough?","volume":"5","author":"Karthik","year":"2006","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2026080708561535700_zwag377-B22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijcard.2022.01.059","article-title":"Gender differences in cardiovascular risk factor awareness: results from the ESC EORP EUROASPIRE V registry","volume":"352","author":"Vynckier","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026080708561535700_zwag377-B23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/2047487312446123","article-title":"Social inequality in awareness of cardiovascular risk factors in patients undergoing coronary angiography","volume":"20","author":"Tchicaya","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"2026080708561535700_zwag377-B24","doi-asserted-by":"crossref","first-page":"e010864","DOI":"10.1136\/heartasia-2016-010864","article-title":"Risk perception of cardiovascular diseases among individuals with hypertension in rural Malaysia","volume":"9","author":"Mohd Azahar","year":"2017","journal-title":"Heart Asia"},{"key":"2026080708561535700_zwag377-B25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1471-2458-9-213","article-title":"The effects of gender and age on health related behaviors","volume":"9","author":"Deeks","year":"2009","journal-title":"BMC Public Health"},{"key":"2026080708561535700_zwag377-B26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/2047487312444995","article-title":"Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study","volume":"20","author":"Vedin","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"2026080708561535700_zwag377-B27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/2047487314547652","article-title":"Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry","volume":"22","author":"Ferrari","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"2026080708561535700_zwag377-B28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/2047487316647827","article-title":"Simplifying the audit of risk factor recording and control: a report from an international study in 11 countries","volume":"23","author":"Zhao","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2026080708561535700_zwag377-B29","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/eurheartj\/ehn478","article-title":"Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry","volume":"29","author":"Mehta","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080708561535700_zwag377-B30","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/HJH.0000000000000988","article-title":"Why in 2016 are patients with hypertension not 100% controlled? A call to action","volume":"34","author":"Redon","year":"2016","journal-title":"J Hypertens"},{"key":"2026080708561535700_zwag377-B31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1751-7176.2008.08329.x","article-title":"Barriers to optimal hypertension control","volume":"10","author":"Ogedegbe","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026080708561535700_zwag377-B32","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2026080708561535700_zwag377-B33","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080708561535700_zwag377-B34","first-page":"E114","article-title":"An overview of different health indicators used in the European Health Systems","volume":"58","author":"Gaeta","year":"2017","journal-title":"J Prev Med Hyg"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwag377\/70363186\/zwag377.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwag377\/70363186\/zwag377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:56:29Z","timestamp":1786107389000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwag377\/8747048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwag377","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"zwag377"}}